MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression-Reference-Cited by-同舟云学术

MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression

Published:2020-07-11 Issue:3 Volume:72 Page:949-964
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lozano Elisa¹²,Asensio Maitane¹,Perez‐Silva Laura¹,Banales Jesus M.²³⁴,Briz Oscar¹²,Marin Jose J.G.¹²^ORCID

Affiliation:

1. Experimental Hepatology and Drug Targeting, IBSAL University of Salamanca Salamanca Spain

2. National Institute for the Study of Liver and Gastrointestinal Diseases Carlos III National Health Institute Madrid Spain

3. Department of Hepatology and Gastroenterology, Biodonostia Health Research Institute, Donostia University Hospital University of the Basque Country San Sebastian Spain

4. Ikerbasque Bilbao Spain

Funder

Consejería de Educación, Junta de Castilla y León

Instituto de Salud Carlos III

Fundación Científica Asociación Española Contra el Cáncer

Ministerio de Ciencia e Innovación

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31088

Reference43 articles.

1. Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma

2. Cholangiocarcinoma

3. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

4. Chemoresistance and chemosensitization in cholangiocarcinoma

5. Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models;2024-07-29

2. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment;Journal of Ethnopharmacology;2024-06

3. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition;Biochemical Pharmacology;2024-03

4. Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide;Biomedicine & Pharmacotherapy;2024-01

5. Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases;Genes & Diseases;2023-06